Xilio Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Xilio Therapeutics Inc's ROI in the second quarter of 2026?
Xilio Therapeutics Inc recorded a cumulative net loss of $-22 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -21.56%.

Within the Healthcare sector Xilio Therapeutics Inc achieved the highest return on investment. While the total ranking for ROI remained the same, compared to the first quarter of 2026 at no. .

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	98.44 %	125.34 %	104.86 %	64.68 %	15.86 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	109	121	98	77	81
Return On Investment (TTM)	-21.56 %	-33.23 %	-44.69 %	-92.84 %	-110.19 %
XLO's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	7.49 %	20.16 %	24.42 %	23.48 %	22.06 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-22	-31	-35	-58	-56

XLO Company Profile >> Back to XLO Roi Comparisons >> See Annual XLO Return On Investment

Return On Investment XLO's Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Investment Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Xilio Therapeutics Inc's II. Quarter Investments	$ 109 Millions	XLO's Balance sheet
Xilio Therapeutics Inc's II. Quarter Income	$ -6 Millions	Quarterly XLO's Income Statement
XLO's Income by Division		See XLO's Income by Division

XLO Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	98	37	37	109	195
Y / Y Investment Growth	166.99 %	0.09 %	-66.17 %	-44.23 %	-
Net Income in Millions	0	-58	-76	-88	-76
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	0 %	-158.01 %	-207.47 %	-81.04 %	-38.84 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
XLO's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for XLO's Competitors
Subscribers only: Roi for Xilio Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for XLO's Customers

Other Ratios
XLO's Roa	XLO's Inventory Turnover Ratio	XLO's Growth Rates	XLO's Dividend Statistics
	XLO's Profitability Ratios	XLO's Asset Turnover Ratio	XLO's Dividend Growth
XLO's Roe	XLO's Valuation Ratios	XLO's Financial Strength Ratios	XLO's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-04T10:54:16+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.